Nuclear Regulatory Commission July 25, 2018 – Federal Register Recent Federal Regulation Documents

The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on September 20-21, 2018. Tentative agenda items to be discussed during the public session include: (1) Medical-related events; (2) an update on nursing mother guidelines; (3) licensing of thorium-227 chloride; (4) an update on the yttrium-90 microspheres licensing guidance revision; and (5) status of the NRC's training and experience (T&E) evaluation and stakeholder outreach plans for T&E. The agenda is subject to change. The current agenda and any updates will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/ meetings/2018.html or may be requested by emailing Ms. Lisa Dimmick at the contact information below. Purpose: Discuss issues related to 10 CFR part 35, Medical Use of Byproduct Material. Date and Time for Open Sessions: September 20, 2018, from 8:30 a.m. to 3:00 p.m. and September 21, 2018, from 8:30 a.m. to 3:30 p.m. Eastern Standard Time. Date and Time for Closed Sessions: September 20, 2018, from 8:00 a.m. to 8:30 a.m. and 3:30 p.m. to 5:00 .pm. Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North Building, Commission Hearing Room, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Dimmick using the information below. The meeting will also be webcast live at https://video.nrc.gov/. Contact Information: Lisa Dimmick, email: lisa.dimmick@nrc.gov, telephone: (301) 415-0694.